标题
Long-term effects of cariprazine exposure on dopamine receptor subtypes
作者
关键词
-
出版物
CNS SPECTRUMS
Volume 19, Issue 03, Pages 268-277
出版商
Cambridge University Press (CUP)
发表日期
2013-11-08
DOI
10.1017/s1092852913000680
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cariprazine in Schizophrenia: Clinical Efficacy, Tolerability, and Place in Therapy
- (2013) Leslie Citrome ADVANCES IN THERAPY
- Cariprazine in Bipolar Disorder: Clinical Efficacy, Tolerability, and Place in Therapy
- (2013) Leslie Citrome ADVANCES IN THERAPY
- Pharmacological approaches in bipolar disorders and the impact on cognition: a critical overview
- (2012) V. V. Dias et al. ACTA PSYCHIATRICA SCANDINAVICA
- Pharmacokinetics and metabolism update for some recent antipsychotics
- (2011) Silvio Caccia Expert Opinion on Drug Metabolism & Toxicology
- Emerging drugs for schizophrenia
- (2011) Falko Biedermann et al. EXPERT OPINION ON EMERGING DRUGS
- Cariprazine (RGH-188), a potent D3/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents
- (2011) István Gyertyán et al. NEUROCHEMISTRY INTERNATIONAL
- The Physiology, Signaling, and Pharmacology of Dopamine Receptors
- (2011) J.-M. Beaulieu et al. PHARMACOLOGICAL REVIEWS
- Current perspectives on the selective regulation of dopamine D2 and D3 receptors
- (2010) Dong Im Cho et al. ARCHIVES OF PHARMACAL RESEARCH
- Cognition and disability in bipolar disorder: lessons from schizophrenia research
- (2010) Philip D Harvey et al. BIPOLAR DISORDERS
- Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?
- (2010) Richard Mailman et al. CURRENT PHARMACEUTICAL DESIGN
- Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist-Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile
- (2010) B. Kiss et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Enhanced cognitive performance of dopamine D3 receptor “knock-out” mice in the step-through passive-avoidance test: Assessing the role of the endocannabinoid/endovanilloid systems
- (2010) Vincenzo Micale et al. PHARMACOLOGICAL RESEARCH
- Antipsychotic Drugs for First-Episode Schizophrenia
- (2009) Kayvon Salimi et al. CNS DRUGS
- Asenapine exerts distinctive regional effects on ionotropic glutamate receptor subtypes in rat brain
- (2009) Frank I. Tarazi et al. SYNAPSE
- Asenapine induces differential regional effects on serotonin receptor subtypes
- (2008) FI Tarazi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: II. behavioural characterisation of RG-15
- (2008) István Gyertyán et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection
- (2008) J. A. Lieberman et al. PHARMACOLOGICAL REVIEWS
- Differential regional and dose-related effects of asenapine on dopamine receptor subtypes
- (2008) Frank I. Tarazi et al. PSYCHOPHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now